Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Dainippon Sumitomo Pharma Co Ltd
Dainippon Sumitomo Pharma Co Ltd_20100107
Dainippon Sumitomo Pharma Co Ltd_20100114
  

Dainippon Sumitomo Pharma Co Ltd patents

Recent patent applications related to Dainippon Sumitomo Pharma Co Ltd. Dainippon Sumitomo Pharma Co Ltd is listed as an Agent/Assignee. Note: Dainippon Sumitomo Pharma Co Ltd may have other listings under different names/spellings. We're not affiliated with Dainippon Sumitomo Pharma Co Ltd, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "D" | Dainippon Sumitomo Pharma Co Ltd-related inventors




Date Dainippon Sumitomo Pharma Co Ltd patents (updated weekly) - BOOKMARK this page
06/16/16Method for cancer immunotherapy
09/17/15Imidazole derivative
03/19/15Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
01/29/15Novel 1-substituted indazole derivative
11/27/14Lurasidone novel dosage regimens and use thereof for the treatment, prevention, and/or management of at least one cns disorder
10/09/14Oral disintegrating tablet
09/11/14Process of preparing a quaternary ammonium salt using phosphate
08/21/14Pharmaceutical composition
06/26/14Uracil derivative and use thereof for medical purposes
05/15/14Tablet having improved elution properties
04/17/14Rat embryonic stem cell
04/10/14Process for producing optically active succinimide derivatives and intermediates thereof
02/13/149-substituted 8-oxoadenine compound
01/30/14Pyrazole compound
10/31/13Medicament for treating mental and behavioural disorders
10/24/13Diagnostic drug and diagnostic alzheimer's disease
08/22/13Cyclic amide derivative
08/01/13Human monoclonal antibody
08/01/13Process for producing optically active succinimide derivatives
05/16/13Treatment drug for autoimmune diseases and allergic diseases
05/09/13Method for prevention or treatment of metabolic syndrome
05/09/13Biaryl amide derivative or pharmaceutically acceptable salt thereof
01/17/13Method of treatment for mental disorders
01/03/13Drug for inflammatory bowel disease
10/11/12Benzylpiperizine compound
09/20/12Emulsified composition for dilution and cancer vaccine composition
09/06/128-azabicyclo[3.2.1]octane-8-carboxamide derivative
08/23/12N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof
07/12/12Novel adenine compound and use thereof
07/12/12Genes with es cell-specific expression
07/05/128-oxodihydropurine derivative
06/28/12Therapeutic agent for senile dementia
06/07/12Human monoclonal antibody
06/07/12Rat embryonic stem cell
06/07/12Biphenylacetamide derivative
05/31/12Orally rapidly disintegrating tablet that contains two or more types of particles
05/24/12Benzyl piperidine compound
05/17/12N-substituted-cyclic amino derivative
03/15/12Dry-coated orally-disintegrating tablet
03/08/123-(4-aminophenyl)-2-furancarboxylic acid derivative and pharmaceutically acceptable salt thereof
02/09/12Process for producing optically active succinimide derivatives and intermediates thereof
01/26/12Novel recombinant adenovirus vector having a reduced side effect
01/12/12Novel medicament for treating cognitive impairment
12/15/119-substituted 8-oxoadenine compound
12/01/11Novel bicyclic heterocyclic compound
10/27/11Process of a quaternary ammonium salt
10/27/11Molecular marker for cancer stem cell
10/27/11Novel useful therapeutic agent for lower urinary tract symptom
10/27/11Therapeutic agent for chronic obstructive pulmonary disease
10/27/11Process of a quaternary ammonium salt using phosphate
09/29/11Method for treating schizophrenia and related diseases
09/22/11Method for cancer immunotherapy
09/15/11Biphenylacetamide derivative
09/01/11Agent for treatment of diabetes
08/18/11Tumor antigen peptide and use thereof
07/28/11Cycloalkane derivative
07/07/11Electrocardiogram chart device and method thereof
05/26/11Cycloalkane derivative
05/19/11Benzylpiperizine compound
05/12/11Pain judging device
05/05/11Medicament for treating cancer
05/05/11Therapeutic or preventive agents for ischemic neuropathy
05/05/11Tablet quickly disintegrating in the oral cavity and producing the same
03/24/11Aminopyrazole amide derivative
03/03/11Orally disintegrating tablets
Patent Packs
02/03/11Tablet having improved elution properties
01/27/11Lyophilized preparation of stabilized anthracycline compounds
01/13/11Bicyclic pyrrole compound
01/06/11Cycloalkane derivative
11/25/10Salts 756
11/11/10Orally disintegrating tablet
11/11/10Stable crystal of beta-lactam compound
10/07/10Preparation composition
09/23/10Biological information trend display device and method thereof
07/29/10Novel fused pyrole derivative
07/15/10Cyclic aminoalkylcarboxamide derivative
06/24/10Aromatic sulfone compound as aldosterone receptor modulator
05/06/10Benzylpiperizine compound
04/22/10Oral disintegrating tablet
04/15/10Granular preparation prevented from caking
Patent Packs
03/11/10Novel peptide compound
03/04/10Amide derivative
01/14/10Benzothiazin-3-one compound and intermediate therefor
01/07/10Method for producing optically active succinimide compound
01/07/10Method for producing succinimide compound
12/17/09Diagnosis of acute enterocolitis by determination of intestinal fatty acid-binding protein in the blood
11/19/09Novel memory ctl induction potentiator
07/30/09Bicyclic pyrrole derivatives
07/23/09Method for stabilization of isoxazole compound
07/09/09In vivo screening therapeutic agent for memory/learning dysfunctions by schizophrenia
06/11/09Bicyclic pyrrole derivatives
05/21/09Granular preparation containing biguanide compound
05/21/09Oxindole derivative as feeding control agent
05/21/09Novel 2-quinolone derivative
04/23/09Novel recombinant adenovirus vector having a reduced side effect
03/19/09Stable tablet containing droxidopa
01/14/10Benzothiazin-3-one compound and intermediate therefor
01/07/10Method for producing succinimide compound







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Dainippon Sumitomo Pharma Co Ltd in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Dainippon Sumitomo Pharma Co Ltd with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';